Clinical Trials Logo

Filter by:
NCT ID: NCT06195202 Recruiting - Breast Cancer Clinical Trials

Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS)

Start date: September 1, 2023
Phase:
Study type: Observational [Patient Registry]

The investigators intend to conduct a prospective cohort study to detect E2 levels during endocrine therapy in Chinese breast cancer patients using LC-MS/MS methods, and to determine the proportion of patients with premenopausal E2 levels (OFR or E2 insufficiency) during AIs or FUL endocrine therapy. To further explore the correlation between serum E2 levels and the efficacy of endocrine therapy in Chinese patients, so as to ensure the safety and efficacy of endocrine therapy for patients, and pave the way for further providing more accurate individualized treatment programs.

NCT ID: NCT06195189 Recruiting - Clinical trials for Non Small Cell Lung Cancer

Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure:Phase I/II

WU-KONG36
Start date: February 29, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

To access the anti-tumor efficacy, safety and tolerability of Sunvozertinib combined with chemotherapy in patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) sensitizing mutations who have progressed following standard TKI therapy.

NCT ID: NCT06195137 Completed - Caffeine Clinical Trials

Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)

Start date: December 13, 2021
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate the efficacy of caffeine and alpha-lipoic acid in the treatment of burning mouth syndrome by symptom assessment with visual analogue scale.

NCT ID: NCT06195124 Recruiting - Clinical trials for Advanced Parkinson's Disease

A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease

Start date: December 2023
Phase: Early Phase 1
Study type: Interventional

A safety study in patients with Parkinson's disease.

NCT ID: NCT06195085 Completed - Desmoid Tumor Clinical Trials

CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors

Start date: July 1, 2013
Phase:
Study type: Observational

This study aimed to explore the long-term outcomes of CT-guided radioactive iodine-125 (I-125) seed implantation (RISI) for recurrent desmoid tumor. A multicenter retrospective study reviewed 38 recurrent desmoid tumor patients receiving RISI from July 2013 to July 2021.The clinical outcomes including overall response rate (ORR), disease control rate (DCR), local control time (LCT), overall survival (OS), adverse events (AEs), and symptom relief rate were statistically assessed.

NCT ID: NCT06194981 Recruiting - Gastric Cancer Clinical Trials

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

Start date: January 11, 2024
Phase:
Study type: Observational

The goal of this retrospective study is to compare the efficacy and safety of 3-4 months to 5-6 months of CapOx/SOX adjuvant chemotherapy in pathological N3 gastric cancer patients.

NCT ID: NCT06194968 Recruiting - Clinical trials for Acute Ischemic Stroke

Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study

Start date: December 30, 2023
Phase:
Study type: Observational

The purpose of this study is to to compare the safety and effectiveness of IV urokinase with IV alteplase in the treatment of AIS in patients up to 6 hours from symptom onset.

NCT ID: NCT06194825 Recruiting - Clinical trials for Transthyretin Amyloid Cardiomyopathy

EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy

EPIC-ATTR
Start date: December 1, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the effect of eplontersen compared to placebo on the reduction of serum TTR concentration and long-term safety in Chinese participants with hereditary or wild-type transthyretin amyloid cardiomyopathy.

NCT ID: NCT06194734 Recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

Start date: February 5, 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of KC1036 versus investigator's choice of chemotherapy in patients with advanced recurrent or metastatic esophageal squamous cell carcinoma

NCT ID: NCT06194708 Recruiting - Rectal Cancer Clinical Trials

Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer (NORESTO Study)

Start date: May 15, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about in mid-low rectal patients who received temporary ostomies after surgery of the primary tumors. The main questions it aims to answer are: - To explore the proportion of temporary stomas that cannot be reversed after radical surgery for mid-low rectal cancer and their main causes. - To use the basic information we collected from patients before and during surgery to develop an individualized model for predicting the time of stoma reversal and explore the risk factors affecting stoma reversal.